Medtronic rolls out novel CRT-D leads in Europe; UCLA makes Alzheimer's Dx headway;

 @FierceMedDev: Report: Life Tech may have found a buyer after all. Story | Follow @FierceMedDev

 @MarkHFierce: Royalty financing may not be new, but it's novel for the medical device world. More | Follow @MarkHFierce

 @DamianFierce: Boston Scientific is holding back some data on Watchman, and market watchers are a little spooked. Report | Follow @DamianFierce

> With CE mark in hand, Medtronic ($MDT) is kicking off the European launch of its Attain Performa portfolio of quadripolar leads, designed to fit its CRT-D devices. News

> Boston Scientific ($BSX) has launched two new sizes of its Rubicon Support Catheter, designed to treat peripheral artery disease. More

> Researchers at UCLA have discovered a new genetic risk factor for Alzheimer's that could help diagnose the disease years before it takes effect. Release

> GN Otometrics' ICS Impulse, a bedside ECG for the eye, demonstrated that it can accurately distinguish stroke from other causes of dizziness. Article

> The state-funded Kansas Bioscience Authority is investing $375,000 in local devicemaker Novita Therapeutics, a company that produces dialysis and brain aneurysm technologies. Story

> VisionQuest 20/20 has developed a video game that measures visual acuity and depth perception in schoolchildren, helping to diagnose vision problems that often elude traditional eye tests. Report

Biotech News

 @FierceBiotech: Popular yesterday: Theravance: Biotech's big coming-of-age story. Editor's Corner | Follow @FierceBiotech

@JohnCFierce: TauRx adds $10.5M to its unconventional trove of Alzheimer's PhIII cash. News | Follow @JohnCFierce

@RyanMFierce: Engineering issues have stymied the mini DNA sequencer from Oxford Bio. Blogger says the tech chief is angry: Report | Follow @RyanMFierce

> Japan's Ajinomoto pounces on Althea Tech in $175M buyout deal. News

> TauRx adds $10.5M to its trove of unconventional Alzheimer's PhIII cash. Story

> Teva retrenches on troubled MS blockbuster hopeful as partner grabs $43M. More

> Antibiotics outfit Tetraphase offers price range for $75M biotech IPO. Article

Pharma News

@FiercePharma: Longtime Roche chairman Franz Humer is stepping aside. Who's up next? More | Follow @FiercePharma

@EricPFierce: Pfizer building a plant in Saudi Arabia as MENA area becomes of more interest to Big Pharma. Story | Follow @EricPFierce

> Lilly CEO blasts Europe's drug-pricing moves. Story

> Par to pay $45M for off-label Megace marketing. News

Biomarkers News

> Advanced Cell Diagnostics enables cancer immunotherapy biomarker work. Story

> Australian team builds depression blood test around quinolinic acid. More

> Biomarker shines a light on new pathway to target neuroblastoma. Report

> Scripps scientists spot tropical disease marker in urine. Article

> Ignyta, Lieden University team on RA biomarker research. Item

Drug Delivery News

@MichaelGFierce: Yale researchers improve lupus drug with nanogel delivery. More | Follow @MichaelGFierce

> Actium BioSystems puts the heat on cancer with hyperthermic delivery. Report

> Mercator micro-infusion drug delivery catheter snags CE mark. News

> Combo drug, Dx nanomedicine deliver cancer-fighting payload. Article

> West launches intradermal adapter for shallow injections. Item

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.